Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial

The APPLE COPD-ICON2 trial is a prospective 2×2 factorial, double-blinded proof-of-concept randomised controlled trial targeting patients with chronic obstructive pulmonary disease (COPD) without prior history of cardiovascular disease. The primary goal of this trial is to investigate if treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunadian, Vijay, Wilson, Nina, Stocken, Deborah D., Ali, Hani, McColl, Elaine, Burns, Graham, Howe, Nicola, Fisher, Andrew, De Soyza, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680071/
https://www.ncbi.nlm.nih.gov/pubmed/31403053
http://dx.doi.org/10.1183/23120541.00110-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680071/
https://www.ncbi.nlm.nih.gov/pubmed/31403053
http://dx.doi.org/10.1183/23120541.00110-2019

Ejemplares similares